Biohazard Genetic Engineering Regulation 
Advarra
JUNE 12, 2023
Gene therapy research is exciting and full of promise, but because of the risks involved, it’s also highly regulated, requiring an institutional biosafety committee (IBC) to provide additional oversight and risk assessment. What do the Regulations Say about IBC Review? What do the Regulations Say about IBC Review?
Advarra
OCTOBER 26, 2023
Controlled Environment and IP Containment The potential for a release, and the risk associated with a genetically engineered IP, are part of the IBC’s assessment purview under National Institutes of Health (NIH) Guidelines. And don’t forget to affix a biohazard sticker to the exterior for quick and clear identification.
Expert insights. Personalized for you.
98 
Let's personalize your content